Search - tctmd.com

Displaying 41 - 60 of 87

Sort: Relevancy | Date

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

News Industry News

Keystone Heart Raises $14M in Series B Funding for Cerebral Protection Devices

May 15, 2014

News Daily News

Los Resultados Clínicos de la Implantación de Stents Carotídeos son Parecidos en las Estenosis inducidas por Radiación y en las Ateroscleróticas

L.A. McKeown

April 11, 2014

News Daily News

Clinical Outcomes of Carotid Stenting Comparable in Radiation-Induced and Atherosclerotic Stenoses

L.A. McKeown

April 11, 2014

News Daily News

‘Urgent’ Stenting or Surgery Safe After Thrombolysis for Stroke

Jason Kahn

February 27, 2014

News Industry News

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

February 17, 2014

News Daily News

Contemporary Carotid Stenting Practice Associated With Low Adverse Event Rates

Yael L. Maxwell

January 16, 2014

News Daily News

La Práctica Contemporánea de Implantación de Stents Carotídeos se asocia a Índices Bajos de Episodios Adversos

Yael L. Maxwell

January 16, 2014

News Conference News TCT 2013

Clamping Intolerance Predicted by Low Clamping Pressure in Carotid Stenting

November 07, 2013

News Daily News

No Long-term Decline in Cognitive Performance After TAVR

Jason Kahn

October 25, 2013

News Daily News

Un Pequeño Estudio Sugiere que la Protección con Filtro es Más Eficaz que la Inversión del Flujo en la Implantación de Stents Carotídeos

L.A. McKeown

October 11, 2013

News Daily News

Several Predictors Found for Cerebral Embolization After Protected Carotid Stenting

Yael L. Maxwell

June 28, 2013

News Daily News

Se Hallan Varios Predictores de la Embolización Cerebral tras Implantar Stents Carotídeos Protegidos

Yael L. Maxwell

June 28, 2013

Presentation TVT 2013

Cerebral Embolic Protection Devices

Presenter: Eberhard Grube

June 14, 2013

Presentation

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Presenter: L. Bijuklic

June 06, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

News Daily News

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Yael L. Maxwell

May 17, 2013

News Daily News

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Yael L. Maxwell

May 17, 2013

News Daily News

Silent Lesions Common after CAS, but Do Not Impact Hard Events

April 05, 2013

News Daily News

Las Lesiones Silenciosas son Frecuentes tras la CAS pero No Influyen en los Episodios Objetivos

April 05, 2013

Advertisement

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Keystone Heart Raises $14M in Series B Funding for Cerebral Protection Devices

Los Resultados Clínicos de la Implantación de Stents Carotídeos son Parecidos en las Estenosis inducidas por Radiación y en las Ateroscleróticas

Clinical Outcomes of Carotid Stenting Comparable in Radiation-Induced and Atherosclerotic Stenoses

‘Urgent’ Stenting or Surgery Safe After Thrombolysis for Stroke

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

Contemporary Carotid Stenting Practice Associated With Low Adverse Event Rates

La Práctica Contemporánea de Implantación de Stents Carotídeos se asocia a Índices Bajos de Episodios Adversos

Clamping Intolerance Predicted by Low Clamping Pressure in Carotid Stenting

No Long-term Decline in Cognitive Performance After TAVR

Un Pequeño Estudio Sugiere que la Protección con Filtro es Más Eficaz que la Inversión del Flujo en la Implantación de Stents Carotídeos

Several Predictors Found for Cerebral Embolization After Protected Carotid Stenting

Se Hallan Varios Predictores de la Embolización Cerebral tras Implantar Stents Carotídeos Protegidos

Cerebral Embolic Protection Devices

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Silent Lesions Common after CAS, but Do Not Impact Hard Events

Las Lesiones Silenciosas son Frecuentes tras la CAS pero No Influyen en los Episodios Objetivos

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content